Adipocyte size as a determinant of metabolic disease and adipose tissue dysfunction

Critical Reviews in Clinical Laboratory Sciences

Volumn 52, Issue 6, 2015, Pages 301-313

  Laforest, Sofia ^a,b,c   Labrecque, Jennifer ^a,b,c   Michaud, Andréanne ^a,b,c   Cianflone, Katherine ^c   Tchernof, André ^a,b,c  

^a University Laval   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c LAVAL UNIVERSITY   (Canada)

Author keywords

Adipocyte hypertrophy; Adipokines; Metabolic syndrome; Obesity; Subcutaneous fat; Visceral fat

Indexed keywords

ADIPONECTIN; COLLAGENASE; LEPTIN; OSMIUM TETRAOXIDE;

ADIPOCYTE; ADIPOCYTE HYPERTROPHY; ADIPOGENESIS; ADIPOSE TISSUE DYSFUNCTION; ANALYTIC METHOD; ANGIOGENESIS; CARDIOMETABOLIC RISK; CELL SIZE; FLOW CYTOMETRY; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; HUMAN; HYPERTROPHY; HYPOXIA; INFLAMMATION; INSULIN METABOLISM; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LIPID BLOOD LEVEL; LIPID METABOLISM; LIPID STORAGE; MALIGNANT NEOPLASTIC DISEASE; METABOLIC DISORDER; METABOLIC SYNDROME X; MULTISIZER COUNTER ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; OSMIUM TETROXIDE FIXATION METHOD; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; SCANNING ELECTRON MICROSCOPY; WEIGHT REDUCTION; EVIDENCE BASED MEDICINE; LIPOMATOSIS; PANNICULITIS; PATHOLOGY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ADIPOCYTES; CELL SIZE; EVIDENCE-BASED MEDICINE; HUMANS; LIPOMATOSIS; METABOLIC DISEASES; PANNICULITIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84954375122     PISSN: 10408363     EISSN: 1549781X     Source Type: Journal    
DOI: 10.3109/10408363.2015.1041582     Document Type: Review

References (124)

1. Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014;384:766-81.
2. Tchernof A, Despres JP. Pathophysiology of human visceral obesity: an update. Physiol Rev 2013;93:359-404.
3. Bluher M. The distinction of metabolically 'healthy' from 'unhealthy' obese individuals. Curr Opin Lipidol 2010;21:38-43.
4. Kramer CK, Zinman B, Retnakaran R. Are metabolically healthy overweight and obesity benign conditions?: a systematic review and meta-Analysis. Ann Intern Med 2013;159:758-69.
5. Vague J. Sexual differentiation. a factor affecting the forms of obesity. Presse Meíd 1947;55:339-40.
6. Brochu M, Tchernof A, Dionne IJ, et al. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women J Clin Endocrinol Metab 2001;86:1020-5.
7. Kloting N, Fasshauer M, Dietrich A, et al. Insulin-sensitive obesity. Am J Physiol Endocrinol Metab 2010;299:E506-15.
8. Drolet R, Richard C, Sniderman AD, et al. Hypertrophy and hyperplasia of abdominal adipose tissues in women. Int J Obes 2008;32:283-91.
9. Ryden M, Andersson DP, Bergstrom IB, Arner P. Adipose tissue and metabolic alterations-Regional differences in fat cell size and number matter, but differently-A cross sectional study. J Clin Endocrinol Metab 2014;99:E1870-6.
10. Tchoukalova YD, Votruba SB, Tchkonia T, et al. Regional differences in cellular mechanisms of adipose tissue gain with overfeeding. Proc Natl Acad Sci USA 2010;107:18226-31.
11. Kissebah AH, Vydelingum N, Murray R, et al. Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 1982;54:254-60.
12. Joe AW, Yi L, Even Y, et al. Depot-specific differences in adipogenic progenitor abundance and proliferative response to high-fat diet. Stem Cells 2009;27:2563-70.
13. Bernstein RS, Grant N, Kipnis DM. Hyperinsulinemia and enlarged adipocytes in patients with endogenous hyperlipoproteinemia without obesity or diabetes mellitus. Diabetes 1975;24: 207-13.
14. Bjorntorp P, Grimby G, Sanne H, et al. Adipose tissue fat cell size in relation to metabolism in weight-stabile, physically active men. Horm Metab Res 1972;4:182-6.
15. Haller H, Leonhardt W, Hanefeld M, Julius U. Relationship between adipocyte hypertrophy and metabolic disturbances. Endokrinologie 1979;74:63-72.
16. Hoffstedt J, Arner E, Wahrenberg H, et al. Regional impact of adipose tissue morphology on the metabolic profile in morbid obesity. Diabetologia 2010;53:2496-503.
17. Veilleux A, Caron-Jobin M, Noel S, et al. Visceral adipocyte hypertrophy is associated with dyslipidemia independent of body composition and fat distribution in women. Diabetes 2011;60: 1504-11.
18. Azuma K, Heilbronn LK, Albu JB, et al. Adipose tissue distribution in relation to insulin resistance in type 2 diabetes mellitus. Am J Physiol Endocrinol Metab 2007;293: E435-42.
19. Chandalia M, Lin P, Seenivasan T, et al. Insulin resistance and body fat distribution in South Asian men compared to Caucasian men. PLoS One 2007;2:e812.
20. Henninger AM, Eliasson B, Jenndahl LE, Hammarstedt A. Adipocyte hypertrophy, inflammation and fibrosis characterize subcutaneous adipose tissue of healthy, non-obese subjects predisposed to type 2 diabetes. PLoS One 2014;9:e105262.
21. Ledoux S, Coupaye M, Essig M, et al. Traditional anthropometric parameters still predict metabolic disorders in women with severe obesity. Obesity 2010;18:1026-32.
22. O'Connell J, Lynch L, Cawood TJ, et al. The relationship of omental and subcutaneous adipocyte size to metabolic disease in severe obesity. PLoS One 2010;5:e9997.
23. Hardy OT, Perugini RA, Nicoloro SM, et al. Body mass indexindependent inflammation in omental adipose tissue associated with insulin resistance in morbid obesity. Surg Obes Relat Dis 2011;7:60-7.
24. Lundgren M, Svensson M, Lindmark S, et al. Fat cell enlargement is an independent marker of insulin resistance and 'hyperleptinaemia'. Diabetologia 2007;50:625-33.
25. Faria G, Pestana D, Aral M, et al. Metabolic score: insights on the development and prediction of remission of metabolic syndrome after gastric bypass. Ann Surg 2014;260:279-86.
26. Rodbell M. Metabolism of isolated fat cells. I. Effects of hormones on glucose metabolism. J Biol Chem 1964;239:375-80.
27. Ashwell M, Priest P, Bondoux M, et al. Human fat cell sizing-A quick, simple method. J Lipid Res 1976;17:190-2.
28. Honnor RC, Dhillon GS, Londos C. cAMP-dependent protein kinase and lipolysis in rat adipocytes. I. Cell preparation, manipulation, and predictability in behavior. J Biol Chem 1985; 260:15122-9.
29. Church CD, Berry R, Rodeheffer MS. Isolation and study of adipocyte precursors. Methods Enzymol 2014;537:31-46.
30. Hirsch J, Gallian E. Methods for the determination of adipose cell size in man and animals. J Lipid Res 1968;9:110-19.
31. DeMartinis FD. Very small fat cell populations determined by a modified osmium tetroxide-urea. Am J Physiol 1985;249:C89-96.
32. Etherton TD, Thompson EH, Allen CE. Improved techniques for studies of adipocyte cellularity and metabolism. J Lipid Res 1977; 18:552-7.
33. Bjurulf P. Atherosclerosis and body-build with special reference to size and number of subcutaneous fat cells. Acta Med Scand Suppl 1959;349:1-99.
34. Schremmer CN. [Weight changes of various tissues following formaline fixation]. Frankf Z Pathol 1967;77:299-304.
35. Majka SM, Miller HL, Helm KM, et al. Analysis and isolation of adipocytes by flow cytometry. Methods Enzymol 2014;537: 281-96.
36. Lee YH, Chen SY, Wiesner RJ, Huang YF. Simple flow cytometric method used to assess lipid accumulation in fat cells. J Lipid Res 2004;45:1162-7.
37. Bernstein RL, Hyun WC, Davis JH, et al. Flow cytometric analysis of mature adipocytes. Cytometry 1989;10:469-74.
38. Julien P, Despres JP, Angel A. Scanning electron microscopy of very small fat cells and mature fat cells in human obesity. J Lipid Res 1989;30:293-9.
39. Guo W, Bigornia S, Leizerman I, et al. New scanning electron microscopic method for determination of adipocyte size in humans and mice. Obesity 2007;15:1657-65.
40. Bjornheden T, Jakubowicz B, Levin M, et al. Computerized determination of adipocyte size. Obes Res 2004;12:95-105.
41. Galarraga M, Campion J, Munoz-Barrutia A, et al. Adiposoft: automated software for the analysis of white adipose tissue cellularity in histological sections. J Lipid Res 2012;53:2791-6.
42. Tchoukalova YD, Harteneck DA, Karwoski RA, et al. A quick, reliable, and automated method for fat cell sizing. J Lipid Res 2003;44:1795-801.
43. Chen HC, Farese Jr RV,. Determination of adipocyte size by computer image analysis. J Lipid Res 2002;43:986-9.
44. Osman OS, Selway JL, Kepczynska MA, et al. A novel automated image analysis method for accurate adipocyte quantification. Adipocyte 2013;2:160-4.
45. Arner E, Westermark PO, Spalding KL, et al. Adipocyte turnover: relevance to human adipose tissue morphology. Diabetes 2010;59: 105-9.
46. Imbeault P, Lemieux S, Prud'homme D, et al. Relationship of visceral adipose tissue to metabolic risk factors for coronary heart disease: is there a contribution of subcutaneous fat cell hypertrophy? Metabolism 1999;48:355-62.
47. Heinonen S, Saarinen L, Naukkarinen J, et al. Adipocyte morphology and implications for metabolic derangements in acquired obesity. Int J Obes 2014;38:1423-31.
48. Meena VP, Seenu V, Sharma MC, et al. Relationship of adipocyte size with adiposity and metabolic risk factors in Asian Indians. PLoS One 2014;9:e108421.
49. Bjorntorp P, Bengtsson C, Blohme G, et al. Adipose tissue fat cell size and number in relation to metabolism in randomly selected middle-Aged men and women. Metabolism 1971;20:927-35.
50. Cotillard A, Poitou C, Torcivia A, et al. Adipocyte size threshold matters: link with risk of type 2 diabetes and improved insulinresistance after gastric bypass. J Clin Endocrinol Metab 2014;99: E1466-70.
51. Despres JP, Nadeau A, Tremblay A, et al. Role of deep abdominal fat in the association between regional adipose tissue distribution and glucose tolerance in obese women. Diabetes 1989;38: 304-9.
52. Monickaraj F, Gokulakrishnan K, Prabu P, et al. Convergence of adipocyte hypertrophy, telomere shortening and hypoadiponectinemia in obese subjects and in patients with type 2 diabetes. Clin Biochem 2012;45:1432-8.
53. Weyer C, Foley JE, Bogardus C, et al. Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia 2000;43: 1498-506.
54. Landgraf K, Rockstroh D, Wagner IV, et al. Evidence of early alterations in adipose tissue biology and function and its association with obesity-related inflammation and insulin resistance in children. Diabetes 2015;64:1249-61.
55. Joffe BI, Goldberg RB, Feinstein J, et al. Adipose cell size in obese Africans: evidence against the existence of insulin resistance in some patients. J Clin Pathol 1979;32:471-4.
56. Dubois SG, Heilbronn LK, Smith SR, et al. Decreased expression of adipogenic genes in obese subjects with type 2 diabetes. Obesity 2006;14:1543-52.
57. Roberts R, Hodson L, Dennis AL, et al. Markers of de novo lipogenesis in adipose tissue: associations with small adipocytes and insulin sensitivity in humans. Diabetologia 2009;52:882-90.
58. McLaughlin T, Sherman A, Tsao P, et al. Enhanced proportion of small adipose cells in insulin-resistant vs insulin-sensitive obese individuals implicates impaired adipogenesis. Diabetologia 2007; 50:1707-15.
59. Pasarica M, Xie H, Hymel D, et al. Lower total adipocyte number but no evidence for small adipocyte depletion in patients with type 2 diabetes. Diabetes Care 2009;32:900-2.
60. Yang J, Eliasson B, Smith U, et al. The size of large adipose cells is a predictor of insulin resistance in first-degree relatives of type 2 diabetic patients. Obesity 2012;20:932-8.
61. Hammarstedt A, Graham TE, Kahn BB. Adipose tissue dysregulation and reduced insulin sensitivity in non-obese individuals with enlarged abdominal adipose cells. Diabetol Metab Syndr 2012;4:42.
62. Michaud A, Boulet MM, Veilleux A, et al. Abdominal subcutaneous and omental adipocyte morphology and its relation to gene expression, lipolysis and adipocytokine levels in women. Metabolism 2014;63:372-81.
63. Kranendonk ME, van Herwaarden JA, Stupkova T, et al. Inflammatory characteristics of distinct abdominal adipose tissue depots relate differently to metabolic risk factors for cardiovascular disease: distinct fat depots and vascular risk factors. Atherosclerosis 2015;239:419-27.
64. Srdic B, Stokic E, Korac A, et al. Morphological characteristics of abdominal adipose tissue in normal-weight and obese women of different metabolic profiles. Exp Clin Endocrinol Diabetes 2010; 118:713-18.
65. van Beek L, Lips MA, Visser A, et al. Increased systemic and adipose tissue inflammation differentiates obese women with T2DM from obese women with normal glucose tolerance. Metabolism 2014;63:492-501.
66. Lackey DE, Burk DH, Ali MR, et al. Contributions of adipose tissue architectural and tensile properties toward defining healthy and unhealthy obesity. Am J Physiol Endocrinol Metab 2014;306: E233-46.
67. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-5.
68. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-A new worldwide definition: a Consensus Statement from the International Diabetes Federation. Diabet Med 2006;23:469-80.
69. Anand SS, Tarnopolsky MA, Rashid S, et al. Adipocyte hypertrophy, fatty liver and metabolic risk factors in South Asians: the Molecular Study of Health and Risk in Ethnic Groups (mol-SHARE). PLoS One 2011;6:e22112.
70. Larson-Meyer DE, Heilbronn LK, Redman LM, et al. Effect of calorie restriction with or without exercise on insulin sensitivity, beta-cell function, fat cell size, and ectopic lipid in overweight subjects. Diabetes Care 2006;29:1337-44.
71. Petaja EM, Sevastianova K, Hakkarainen A, et al. Adipocyte size is associated with NAFLD independent of obesity, fat distribution, and PNPLA3 genotype. Obesity 2013;21:1174-9.
72. Koska J, Stefan N, Votruba SB, et al. Distribution of subcutaneous fat predicts insulin action in obesity in sex-specific manner. Obesity 2008;16:2003-9.
73. Johannsen DL, Tchoukalova Y, Tam CS, et al. Effect of eight weeks of overfeeding on ectopic fat deposition and insulin sensitivity: testing the ''adipose tissue expandability'' hypothesis. Diabetes Care 2014;37:2789-97.
74. Jansen HJ, Vervoort GM, van der Graaf M, et al. Liver fat content is linked to inflammatory changes in subcutaneous adipose tissue in type 2 diabetes patients. Clin Endocrinol 2013;79:661-6.
75. Wree A, Schlattjan M, Bechmann LP, et al. Adipocyte cell size, free fatty acids and apolipoproteins are associated with nonalcoholic liver injury progression in severely obese patients. Metabolism 2014;63:1542-52.
76. Aron-Wisnewsky J, Minville C, Tordjman J, et al. Chronic intermittent hypoxia is a major trigger for non-Alcoholic fatty liver disease in morbid obese. J Hepatol 2012;56:225-33.
77. Manneras-Holm L, Leonhardt H, Kullberg J, et al. Adipose tissue has aberrant morphology and function in PCOS: enlarged adipocytes and low serum adiponectin, but not circulating sex steroids, are strongly associated with insulin resistance. J Clin Endocrinol Metab 2011;96:E304-11.
78. Faulds G, Ryden M, Ek I, et al. Mechanisms behind lipolytic catecholamine resistance of subcutaneous fat cells in the polycystic ovarian syndrome. J Clin Endocrinol Metab 2003;88: 2269-73.
79. Ek I, Arner P, Ryden M, et al. A unique defect in the regulation of visceral fat cell lipolysis in the polycystic ovary syndrome as an early link to insulin resistance. Diabetes 2002;51:484-92.
80. Arner P, Backdahl J, Hemmingsson P, et al. Regional variations in the relationship between arterial stiffness and adipocyte volume or number in obese subjects. Int J Obes 2015;39:222-7.
81. Achimastos A, Raison J, Levenson J, Safar M. Adipose tissue cellularity and hemodynamic indexes in obese patients with hypertension. Arch Intern Med 1984;144:265-8.
82. Andersson DP, Eriksson Hogling D, Thorell A, et al. Changes in subcutaneous fat cell volume and insulin sensitivity after weight loss. Diabetes Care 2014;37:1831-6.
83. Lofgren P, Andersson I, Adolfsson B, et al. Long-term prospective and controlled studies demonstrate adipose tissue hypercellularity and relative leptin deficiency in the postobese state. J Clin Endocrinol Metab 2005;90:6207-13.
84. Rizkalla SW, Prifti E, Cotillard A, et al. Differential effects of macronutrient content in 2 energy-restricted diets on cardiovascular risk factors and adipose tissue cell size in moderately obese individuals: a randomized controlled trial. Am J Clin Nutr. 2012; 95:49-63.
85. Varady KA, Tussing L, Bhutani S, Braunschweig CL. Degree of weight loss required to improve adipokine concentrations and decrease fat cell size in severely obese women. Metabolism 2009; 58:1096-101.
86. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004; 4:579-91.
87. Renehan AG, Tyson M, Egger M, et al. Body-mass index and incidence of cancer: a systematic review and meta-Analysis of prospective observational studies. Lancet 2008;371:569-78.
88. D'Esposito V, Passaretti F, Hammarstedt A, et al. Adipocytereleased insulin-like growth factor-1 is regulated by glucose and fatty acids and controls breast cancer cell growth in vitro. Diabetologia 2012;55:2811-22.
89. Morris PG, Hudis CA, Giri D, et al. Inflammation and increased aromatase expression occur in the breast tissue of obese women with breast cancer. Cancer Prev Res 2011;4:1021-9.
90. Farnier C, Krief S, Blache M, et al. Adipocyte functions are modulated by cell size change: potential involvement of an integrin/ERK signalling pathway. Int J Obes Relat Metab Disord 2003;27:1178-86.
91. Farnier C, Krief S, Blache M, et al. The signaling pathway for beta1-integrin/ERKs is involved in the adaptation of adipocyte functions to cell size. Ann N Y Acad Sci 2002;973: 594-7.
92. Laurencikiene J, Skurk T, Kulyte A, et al. Regulation of lipolysis in small and large fat cells of the same subject. J Clin Endocrinol Metab 2011;96:E2045-9.
93. Varlamov O, Somwar R, Cornea A, et al. Single-cell analysis of insulin-regulated fatty acid uptake in adipocytes. Am J Physiol Endocrinol Metab 2010;299:E486-96.
94. Somwar R, Roberts Jr CT, Varlamov O. Live-cell imaging demonstrates rapid cargo exchange between lipid droplets in adipocytes. FEBS Lett 2011;585:1946-50.
95. Rajjo TI, Harteneck DA, Jensen MD. Direct free fatty acid storage in different sized adipocytes from the same depot. Obesity 2014; 22:1275-9.
96. Cote JA, Nadeau M, Leboeuf M, et al. Adipose tissue diacylglycerol acyltransferase activity and blood lipoprotein triglyceride enrichment in women with abdominal obesity. Atherosclerosis 2014;233:172-7.
97. Votruba SB, Mattison RS, Dumesic DA, et al. Meal fatty acid uptake in visceral fat in women. Diabetes 2007;56:2589-97.
98. Serra MC, Ryan AS, Sorkin JD, et al. High adipose LPL activity and adipocyte hypertrophy reduce visceral fat and metabolic risk in obese, older women. Obesity (Silver Spring) 2015;23:602-7.
99. Varlamov O, Chu M, Cornea A, et al. Cell-Autonomous heterogeneity of nutrient uptake in white adipose tissue of rhesus macaques. Endocrinology 2015;156:80-9.
100. McQuaid SE, Hodson L, Neville MJ, et al. Downregulation of adipose tissue fatty acid trafficking in obesity: a driver for ectopic fat deposition Diabetes 2011;60:47-55.
101. Franck N, Stenkula KG, Ost A, et al. Insulin-induced GLUT4 translocation to the plasma membrane is blunted in large compared with small primary fat cells isolated from the same individual. Diabetologia 2007;50:1716-22.
102. Jernas M, Palming J, Sjoholm K, et al. Separation of human adipocytes by size: hypertrophic fat cells display distinct gene expression. FASEB J 2006;20:1540-2.
103. Skurk T, Alberti-Huber C, Herder C, Hauner H. Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab 2007;92:1023-33.
104. Drolet R, Belanger C, Fortier M, et al. Fat depot-specific impact of visceral obesity on adipocyte adiponectin release in women. Obesity 2009;17:424-30.
105. Vargas G, Chandalia M, Jiang Y, et al. Heterogeneity in subcutaneous adipose tissue morphology and metabolic complications in overweight and obese women. Metab Syndr Relat Disord 2013;11:276-82.
106. Bahceci M, Gokalp D, Bahceci S, et al. The correlation between adiposity and adiponectin, tumor necrosis factor alpha, interleukin-6 and high sensitivity C-reactive protein levels. Is adipocyte size associated with inflammation in adults? J Endocrinol Invest 2007;30:210-14.
107. Wahlen K, Sjolin E, Lofgren P. Role of fat cell size for plasma leptin in a large population based sample. Exp Clin Endocrinol Diabetes 2011;119:291-4.
108. Van Harmelen V, Reynisdottir S, Eriksson P, et al. Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes 1998;47:913-17.
109. Couillard C, Mauriege P, Imbeault P, et al. Hyperleptinemia is more closely associated with adipose cell hypertrophy than with adipose tissue hyperplasia. Int J Obes Relat Metab Disord 2000; 24:782-8.
110. Hube F, Lietz U, Igel M, et al. Difference in leptin mRNA levels between omental and subcutaneous abdominal adipose tissue from obese humans. Horm Metab Res 1996;28:690-3.
111. Arner P, Andersson DP, Thorne A, et al. Variations in the size of the major omentum are primarily determined by fat cell number. J Clin Endocrinol Metab 2013;98:E897-901.
112. Maury E, Noel L, Detry R, Brichard SM. In vitro hyperresponsiveness to tumor necrosis factor-Alpha contributes to adipokine dysregulation in omental adipocytes of obese subjects. J Clin Endocrinol Metab 2009;94:1393-400.
113. Hube F, Birgel M, Lee YM, Hauner H. Expression pattern of tumour necrosis factor receptors in subcutaneous and omental human adipose tissue: role of obesity and non-insulin-dependent diabetes mellitus. Eur J Clin Invest 1999;29:672-8.
114. Winkler G, Kiss S, Keszthelyi L, et al. Expression of tumor necrosis factor (TNF)-Alpha protein in the subcutaneous and visceral adipose tissue in correlation with adipocyte cell volume, serum TNF-Alpha, soluble serum TNF-receptor-2 concentrations and C-peptide level. Eur J Endocrinol 2003;149:129-35.
115. Arner E, Ryden M, Arner P. Tumor necrosis factor alpha and regulation of adipose tissue. N Engl J Med 2010;362: 1151-3.
116. Michaud A, Drolet R, Noel S, et al. Visceral fat accumulation is an indicator of adipose tissue macrophage infiltration in women. Metabolism 2012;61:689-98.
117. El Bouazzaoui F, Henneman P, Thijssen P, et al. Adipocyte telomere length associates negatively with adipocyte size, whereas adipose tissue telomere length associates negatively with the extent of fibrosis in severely obese women. Int J Obes 2014;38: 746-9.
118. Hallgren P, Sjostrom L, Hedlund H, et al. Influence of age, fat cell weight, and obesity on O2 consumption of human adipose tissue. Am J Physiol 1989;256:E467-74.
119. Yin X, Lanza IR, Swain JM, et al. Adipocyte mitochondrial function is reduced in human obesity independent of fat cell size. J Clin Endocrinol Metab 2014;99:E209-16.
120. Villaret A, Galitzky J, Decaunes P, et al. Adipose tissue endothelial cells from obese human subjects: differences among depots in angiogenic, metabolic, and inflammatory gene expression and cellular senescence. Diabetes 2010;59:2755-63.
121. Lemoine AY, Ledoux S, Queguiner I, et al. Link between adipose tissue angiogenesis and fat accumulation in severely obese subjects. J Clin Endocrinol Metab 2012;97:E775-80.
122. Faber DR, Moll FL, Vink A, et al. Adipose tissue quantity and composition contribute to adipokine concentrations in the subclavian vein and the inferior mesenteric vein. Int J Obes 2012;36: 1078-85.
123. Lessard J, Tchernof A. Depot-And obesity-related differences in adipogenesis. Clin Lipidol 2012;7:587-96.
124. Lessard J, Laforest S, Pelletier M, et al. Low abdominal subcutaneous preadipocyte adipogenesis is associated with visceral obesity, visceral adipocyte hypertrophy, and a dysmetabolic state. Adipocyte 2014;3:197-205.